Why the study?
A small aortic annulus poses significant challenges during aortic valve replacement for severe aortic stenosis, and the ideal prosthetic valve remains elusive.
What are the optimal surgical and transcatheter management strategies for severe aortic stenosis in patients with a small aortic annulus?
What are the optimal surgical and transcatheter management strategies for severe aortic stenosis in patients with a small aortic annulus?
In patients with a small aortic annulus, alternative techniques like stentless, sutureless, rapid deployment valves, and TAVR offer hemodynamic advantages over conventional stented bioprostheses, though optimal strategy depends on patient comorbidities and anatomy.
Ideal prosthetic valve for small aortic annulus remains elusive; leaves open need for head-to-head trials of modern options.
BACKGROUND: Although aortic valve replacement (AVR) has been the standard of treatment for severe aortic stenosis, a small aortic annulus (SAA) poses significant challenges. Improvements in valve designs and evolution in surgical techniques have led to improved outcomes, however, the ideal prosthetic valve remains elusive. METHODS: We performed a comprehensive literature review to discuss the surgical management of aortic stenosis, with a special focus on patients with SAA. RESULTS: Stentless valves and root replacement techniques have been shown to overcome the hemodynamic challenges associated with conventional stented bioprostheses, but are technically challenging and require longer cross-clamp times. Sutureless and rapid deployment valves mitigate the long operative time while maintaining the hemodynamic advantages. The use of transcatheter AVR has emerged as another reasonable alternative and has shown promise among patients with SAA, however, long-term outcomes are awaited. CONCLUSION: There is no consensus regarding the type of valve prosthesis or replacement technique among patients with SAA. Consideration of patient comorbidities and valvular anatomy is paramount in planning the optimal strategy for AVR. Further long-term clinical trials are necessary to assess outcomes and achieve progress toward the development of the ideal prosthesis.
No takes yet. Share an insight, caveat, or question.
Vaidya et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: